TY - JOUR
T1 - 12S-lipoxygenase protein associates with α-actin fibers in human umbilical artery vascular smooth muscle cells
AU - Weisinger, Gary
AU - Limor, Rona
AU - Marcus-Perlman, Yonit
AU - Knoll, Esther
AU - Kohen, Fortune
AU - Schinder, Vera
AU - Firer, Michael
AU - Stern, Naftali
PY - 2007/5/11
Y1 - 2007/5/11
N2 - The current study sets out to characterize the intracellular localization of the platelet-type 12S-lipoxygenase (12-LO), an enzyme involved in angiotensin-II induced signaling in vascular smooth muscle cells (VSMC). Immunohistochemical analysis of VSMC in vitro or human umbilical arteries in vivo showed a clear cytoplasmic localization. On immunogold electron microscopy, 12-LO was found primarily associated with cytoplasmic VSMC muscle fibrils. Upon angiotensin-II treatment of cultured VSMC, immunoprecipitated 12-LO was found bound to α-actin, a component of the cytoplasmic myofilaments. 12-LO/α-actin binding was blocked by VSMC pretreatment with the 12-LO inhibitors, baicalien or esculetine and the protein synthesis inhibitor, cycloheximide. Moreover, the binding of 12-LO to α-actin was not associated with 12-LO serine or tyrosine phosphorylation. These observations suggest a previously unrecognized angiotensin-II dependent protein interaction in VSMC through which 12-LO protein may be trafficked, for yet undiscovered purposes towards the much more abundantly expressed cytoskeletal protein α-actin.
AB - The current study sets out to characterize the intracellular localization of the platelet-type 12S-lipoxygenase (12-LO), an enzyme involved in angiotensin-II induced signaling in vascular smooth muscle cells (VSMC). Immunohistochemical analysis of VSMC in vitro or human umbilical arteries in vivo showed a clear cytoplasmic localization. On immunogold electron microscopy, 12-LO was found primarily associated with cytoplasmic VSMC muscle fibrils. Upon angiotensin-II treatment of cultured VSMC, immunoprecipitated 12-LO was found bound to α-actin, a component of the cytoplasmic myofilaments. 12-LO/α-actin binding was blocked by VSMC pretreatment with the 12-LO inhibitors, baicalien or esculetine and the protein synthesis inhibitor, cycloheximide. Moreover, the binding of 12-LO to α-actin was not associated with 12-LO serine or tyrosine phosphorylation. These observations suggest a previously unrecognized angiotensin-II dependent protein interaction in VSMC through which 12-LO protein may be trafficked, for yet undiscovered purposes towards the much more abundantly expressed cytoskeletal protein α-actin.
KW - Actin
KW - Angiotensin II
KW - Arteries
KW - Lipoxygenase
KW - Protein-interaction
KW - Vascular smooth muscle
UR - http://www.scopus.com/inward/record.url?scp=34047185714&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2007.03.012
DO - 10.1016/j.bbrc.2007.03.012
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 17379189
AN - SCOPUS:34047185714
SN - 0006-291X
VL - 356
SP - 554
EP - 560
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -